We send you the link and short introduction to European Industrial Hemp Association’s statement on recommendations of the 40th ECDD on Cannabidiol and contribution to the 41st ECDD Critical reviews of Cannabis-related substances.
“The European Industrial Hemp Association (EIHA) welcomes an independent scientific evaluation of all substances related to the Cannabis sativa L. plant.
However, besides the weak points of the data collection process prior to the 40th ECDD, we would like to point out inconsistencies in the Critical review papers.
However, we would like to point out several inconsistencies and weak points of the data collection
process, and of the Review papers.
As in June, we formally object to the late publication of reports and non-timely deadlines. The Guidance on the WHO review of psychoactive substances for international control states that documentation should be provided and uploaded on the WHO website at least 30 days prior to the meeting. In June, the documentation was provided only 5 days before the meeting, this time, the documentation has been made public 18 days before.”
You can read the full document here